HomeNewsWorldPakistan unlikely to exit grey list' as FATF meets to decide its fate: Report

Pakistan unlikely to exit grey list' as FATF meets to decide its fate: Report

The virtual FATF plenary will be held in Paris from February 22 to 25 to consider cases of various countries on the grey list, including Pakistan, and a decision will be made at the conclusion of the meetings

February 21, 2021 / 21:25 IST
Story continues below Advertisement
Pakistani Prime Minister Imran Khan
Pakistani Prime Minister Imran Khan

Pakistan is unlikely to exit the 'grey list' of the FATF as some European countries have taken the stand that Islamabad has not fully implemented all the points of a plan of action set by it, a media report said on Sunday, on the eve of the plenary meeting of the global watchdog for money laundering and terror financing.

The Paris-based Financial Action Task Force had placed Pakistan on the grey list in June 2018 and asked Islamabad to implement a plan of action to curb money laundering and terror financing by the end of 2019 but the deadline was extended later on due to COVID-19 pandemic. The virtual FATF plenary will be held in Paris from February 22 to 25 to consider cases of various countries on the grey list, including Pakistan, and a decision will be made at the conclusion of the meetings, Dawn newspaper reported.

Story continues below Advertisement

India, Pakistan must resolve Jammu & Kashmir issue peacefully: Pakistan Army Chief General Bajwa

In the last plenary held in October 2020, the FATF concluded that Pakistan will continue in its grey list till February 2021 as it has failed to fulfil six out of 27 obligations of the global money laundering and terrorist financing watchdog that include failure to take action against two of India's most wanted terrorists Jaish-e Mohammad chief Maulana Masood Azhar and Jamaat-ud-Dawah head Hafiz Saeed. Azhar and Saeed are most wanted terrorists in India for their involvement in numerous terrorist acts, including 26/11 Mumbai terror attacks and bombing of a CRPF bus at Pulwama in Jammu and Kashmir last year.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show